215 related articles for article (PubMed ID: 27807729)
21. Sentinel lymph node status affects long-term survival in patients with intermediate-thickness melanoma.
G Lben K; Berberoğlu U; Altınyollar H; Kınaş V; Turanlı S
J Cancer Res Ther; 2016; 12(2):840-4. PubMed ID: 27461661
[TBL] [Abstract][Full Text] [Related]
22. Transected thin melanoma: Implications for sentinel lymph node staging.
Herbert G; Karakousis GC; Bartlett EK; Zaheer S; Graham D; Czerniecki BJ; Fraker DL; Ariyan C; Coit DG; Brady MS
J Surg Oncol; 2018 Mar; 117(4):567-571. PubMed ID: 29194673
[TBL] [Abstract][Full Text] [Related]
23. [An individualized prognosis for truncal melanoma? A series of 77 cases].
Martel P; Garrido I; Ferron G; Gangloff D; Chevreau C; Maisongrosse V; Zerdoud S; Simon C; Chapman T
Bull Cancer; 2010 Aug; 97(8):901-7. PubMed ID: 20392688
[TBL] [Abstract][Full Text] [Related]
24. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
Gershenwald JE; Colome MI; Lee JE; Mansfield PF; Tseng C; Lee JJ; Balch CM; Ross MI
J Clin Oncol; 1998 Jun; 16(6):2253-60. PubMed ID: 9626228
[TBL] [Abstract][Full Text] [Related]
25. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
26. Long-term prognosis and significance of the sentinel lymph node in head and neck melanoma.
Parrett BM; Kashani-Sabet M; Singer MI; Li R; Thummala S; Fadaki N; Leong SP
Otolaryngol Head Neck Surg; 2012 Oct; 147(4):699-706. PubMed ID: 22535913
[TBL] [Abstract][Full Text] [Related]
27. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
29. Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma.
Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
J Eur Acad Dermatol Venereol; 2015 May; 29(5):912-8. PubMed ID: 25199412
[TBL] [Abstract][Full Text] [Related]
30. Accuracy and prognostic value of sentinel lymph node biopsy in head and neck melanomas.
Patuzzo R; Maurichi A; Camerini T; Gallino G; Ruggeri R; Baffa G; Mattavelli I; Tinti MC; Crippa F; Moglia D; Tolomio E; Maccauro M; Santinami M
J Surg Res; 2014 Apr; 187(2):518-24. PubMed ID: 24252855
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
33. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
[TBL] [Abstract][Full Text] [Related]
34. Histological regression in primary melanoma: not a predictor of sentinel lymph node metastasis in a cohort of 397 patients.
Socrier Y; Lauwers-Cances V; Lamant L; Garrido I; Lauwers F; Lopez R; Rochaix P; Chevreau C; Payoux P; Viraben R; Paul C; Meyer N
Br J Dermatol; 2010 Apr; 162(4):830-4. PubMed ID: 20030641
[TBL] [Abstract][Full Text] [Related]
35. Predictors of sentinel lymph node metastasis in very thin invasive melanomas.
Kakish H; Sun J; Zheng DX; Ahmed FA; Elshami M; Loftus AW; Ocuin LM; Ammori JB; Hoehn RS; Bordeaux JS; Rothermel LD
Br J Dermatol; 2023 Sep; 189(4):419-426. PubMed ID: 37290803
[TBL] [Abstract][Full Text] [Related]
36. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma.
Sumner WE; Ross MI; Mansfield PF; Lee JE; Prieto VG; Schacherer CW; Gershenwald JE
Cancer; 2002 Jul; 95(2):354-60. PubMed ID: 12124836
[TBL] [Abstract][Full Text] [Related]
37. Age and Lymphovascular Invasion Accurately Predict Sentinel Lymph Node Metastasis in T2 Melanoma Patients.
Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RCG; McMasters KM
Ann Surg Oncol; 2019 Nov; 26(12):3955-3961. PubMed ID: 31392528
[TBL] [Abstract][Full Text] [Related]
38. Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas.
White I; Fortino J; Curti B; Vetto J
Am J Surg; 2014 May; 207(5):702-7; discussion 707. PubMed ID: 24791630
[TBL] [Abstract][Full Text] [Related]
39. Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm.
Han D; Yu D; Zhao X; Marzban SS; Messina JL; Gonzalez RJ; Cruse CW; Sarnaik AA; Puleo C; Sondak VK; Zager JS
Ann Surg Oncol; 2012 Oct; 19(11):3335-42. PubMed ID: 22766986
[TBL] [Abstract][Full Text] [Related]
40. Microsatellitosis in Patients with Melanoma.
Karakousis GC; Gimotty PA; Leong SP; Pockaj BA; White RL; O'Donoghue C; Sinnamon AJ; Bartlett EK; Dueck AC; Gould Rothberg BE; Messina JL; Vetto JT; Sondak VK; Schneebaum S; Kashani-Sabet M; Han D; Faries MB; Zager JS;
Ann Surg Oncol; 2019 Jan; 26(1):33-41. PubMed ID: 30421045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
